Renal resistance thresholds during hypothermic machine perfusion and transplantation outcomes - a retrospective cohort study

Transpl Int. 2018 Jun;31(6):658-669. doi: 10.1111/tri.13146. Epub 2018 Mar 25.

Abstract

Renal resistance (RR), of allografts undergoing hypothermic machine perfusion (HMP), is considered a measure of organ quality. We conducted a retrospective cohort study of adult deceased donor kidney transplant (KT) recipients whose grafts underwent HMP. Our aim was to evaluate whether RR is predictive of death-censored graft failure (DCGF). Of 274 KT eligible for analysis, 59% were from expanded criteria donor. RR was modeled as a categorical variable, using a previously identified terminal threshold of 0.4, and 0.2 mmHg/ml/min (median in our cohort). Hazard ratios (HR) of DCGF were 3.23 [95% confidence interval (CI): 1.12-9.34, P = 0.03] and 2.67 [95% CI: 1.14-6.31, P = 0.02] in univariable models, and 2.67 [95% CI: 0.91-7.86, P = 0.07] and 2.42 [95% CI: 1.02-5.72, P = 0.04] in multivariable models, when RR threshold was 0.4 and 0.2, respectively. Increasing risk of DCGF was observed when RR over the course of HMP was modeled using mixed linear regression models: HR of 1.31 [95% CI: 1.07-1.59, P < 0.01] and 1.25 [95% CI: 1.00-1.55, P = 0.05], in univariable and multivariable models, respectively. This suggests that RR during HMP is a predictor of long-term KT outcomes. Prospective studies are needed to assess the survival benefit of patients receiving KT with higher RR in comparison with staying wait-listed.

Keywords: graft failure; hypothermic machine perfusion; kidney transplantation; renal resistance.

MeSH terms

  • Aged
  • Delayed Graft Function / etiology
  • Female
  • Humans
  • Hypothermia, Induced / methods*
  • Immunosuppression Therapy
  • Kaplan-Meier Estimate
  • Kidney / physiopathology
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Perfusion*
  • Prospective Studies
  • Regression Analysis
  • Retrospective Studies
  • Risk
  • Sensitivity and Specificity
  • Tissue Donors
  • Treatment Outcome